A covalent inhibitor targeting Cys-349 of LIMK1 confers selectivity over LIMK2. - Patteson JB; Manolaridis I; Hong MR; Johnston JM; Mesbahi-Vasey S; Gregory MC; Iwamoto DV; Reid JC; Sanders JM; Lovatt D; McDonald TP; Shurtleff VW; et al. (The Journal of biological chemistry, 2026)